* Jan Abelin MD, Allan Lassus MD Prof. L-112 Biopolymer - Fatbinder as a weight reducer in patients with moderate obesity. Helsinki: Medical research report performed at ARS Medicina; 1994. Brief Information: The Helsinki Study was a randomized, double-blind placebo controlled study performed at ARS Medicina in Helsinki (Finland). Absorbitol Plus was associated with weight loss. The average weight reducing efficacy over 2 and 4 weeks were -4.2kg and -6.4kg respectively). The L112 Biopolymer is effective as a weight reducer with patients with moderate obesity.
**The Rush Presbyterian St. Luke Medical Center Study compared fat-binding characteristics of Absorbitol Plus with six leading chitosans and ten major chitosan-based products, under conditions simulating pH changes occurring during digestion. Data obtained from these studies demonstrated Absorbitol Plus bound approximately 783 grams oil per gram, over three times more fat bound per gram than the average competitor, and almost two times more fat than the best-performing competitive chitosan product.